The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.5K Targets. Of those, 1.4M data for 679K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

19 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Quantitative structure-activity relationships of N2-phenylguanines as inhibitors of herpes simplex virus thymidine kinases.EBI
University of Massachusetts Medical School
Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors.EBI
University of Massachusetts Medical School
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.EBI
University of Massachusetts Medical School
A small molecule inhibitor of fungal histone acetyltransferase Rtt109.EBI
University of Massachusetts Medical School
Design and synthesis of a novel peptidomimetic inhibitor of HIV-1 Tat-TAR interactions: squaryldiamide as a new potential bioisostere of unsubstituted guanidine.EBI
University of Massachusetts Medical School
Fluorogenic probes for monitoring peptide binding to class II MHC proteins in living cells.EBI
University of Massachusetts Medical School
The Ascension of Targeted Covalent Inhibitors.EBI
University of Massachusetts Medical School
Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants.EBI
University of Massachusetts Medical School
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.EBI
University of Massachusetts Medical School
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope.EBI
University of Massachusetts Medical School
Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases.EBI
University of Massachusetts Medical School
Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones.EBI
University of Massachusetts Medical School
Quinoxaline-Based Linear HCV NS3/4A Protease Inhibitors Exhibit Potent Activity against Drug Resistant Variants.EBI
University of Massachusetts Medical School
Development of a Selective Inhibitor of Protein Arginine Deiminase 2.EBI
University of Massachusetts Medical School
Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinases.EBI
University of Massachusetts Medical School
Aza-heteroaryl compounds as PI3K-gamma inhibitorsBDB
Incyte
Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors.BDB
Merck Sharp & Dohme Research Laboratories
Synthesis of 1,7-annulated indoles and their applications in the studies of cyclin dependent kinase inhibitors.BDB
Eli Lilly